November 12, 2025 - 06:03

A recall has been issued for the Vevor Baby Swings due to a significant safety hazard that could lead to serious injury or death. These swings, which were marketed as suitable for infant sleep, have an incline angle exceeding 10 degrees. This design flaw violates mandatory safety standards for infant sleep products and contravenes the Safe Sleep for Babies Act, which prohibits inclined sleepers due to the associated suffocation risks.
Parents and caregivers are urged to stop using the swings immediately and seek a refund. The recall was officially announced on November 6, 2025, affecting a substantial number of units that may still be in use. The safety of infants is paramount, and this recall highlights the critical importance of adhering to safety regulations designed to protect vulnerable children.
If you own a Vevor Baby Swing, it is essential to take action promptly to ensure the safety of your child.
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...